{
  "ticker": "ARN",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02977554",
  "id": "02977554",
  "pages": 8,
  "price_sensitive": false,
  "date": "20250806",
  "time": "1343",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250806/pdf/06mll9fghhfwvc.pdf",
  "summary": "### Director Interest Change Summary (Appendix 3Y):  \n\n**1. Ms Liqun (Quinn) Lee:**  \n- **Change:** Vesting/conversion of 12M Performance Rights into ordinary shares (no cash consideration).  \n- **Resulting holdings:**  \n  - Indirect: 28,223,799 ordinary shares (+12M), 3M Performance Rights remaining.  \n  - Direct: 4,211,932 ordinary shares (adjusted due to super fund transfer).  \n\n**2. Dr Minlu Fu:**  \n- **Change:** Vesting/conversion of 6M Performance Rights into ordinary shares (no cash consideration).  \n- **Resulting holdings:**  \n  - Indirect: 35,568,013 ordinary shares (+6M via Lizeng Pty Ltd), 9.25M Performance Rights remaining.  \n  - Direct: No change (6.66M ordinary shares).  \n\n**Key Impact:**  \n- Dilution from 18M new ordinary shares issued via vested Performance Rights (no cash inflow to company).  \n- No closed-period trading concerns.  \n\n*Omitted: Legal boilerplate, non-material entity names.*",
  "usage": {
    "prompt_tokens": 2507,
    "completion_tokens": 236,
    "total_tokens": 2743,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-08-06T04:31:32.154233"
}